Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

[Survival of patients with biopsy-proven idiopathic pulmonary fibrosis: Chilean National Thorax Institute experience].

Salinas M, Florenzano M, Sabbagh E, Meneses M, Fernández C, Jalilie A, Rodríguez JC, Cavada G, Undurraga Á.

Rev Med Chil. 2014 Jan;142(1):9-15. doi: 10.4067/S0034-98872014000100002. Spanish.

2.

Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.

Strand MJ, Sprunger D, Cosgrove GP, Fernandez-Perez ER, Frankel SK, Huie TJ, Olson AL, Solomon J, Brown KK, Swigris JJ.

Chest. 2014 Sep;146(3):775-85. doi: 10.1378/chest.13-2388.

3.

Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia.

Moua T, Zamora Martinez AC, Baqir M, Vassallo R, Limper AH, Ryu JH.

Respir Res. 2014 Dec 4;15:154. doi: 10.1186/s12931-014-0154-6.

4.

Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.

Alhamad EH, Masood M, Shaik SA, Arafah M.

Clin Respir J. 2008 Oct;2(4):220-6. doi: 10.1111/j.1752-699X.2008.00070.x.

PMID:
20298338
5.

Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.

Kimura M, Taniguchi H, Kondoh Y, Kimura T, Kataoka K, Nishiyama O, Aso H, Sakamoto K, Hasegawa Y.

Respiration. 2013;85(6):456-63. doi: 10.1159/000345221. Epub 2012 Dec 19.

PMID:
23257350
6.

Determinants of the prognosis of idiopathic pulmonary fibrosis.

Novelli F, Tavanti L, Cini S, Aquilini F, Melosini L, Romei C, Sbragia P, Falaschi F, Celi A, Paggiaro P.

Eur Rev Med Pharmacol Sci. 2014;18(6):880-6.

7.

Immunohistochemical and morphometric evaluation of COX 1 and COX-2 in the remodeled lung in idiopathic pulmonary fibrosis and systemic sclerosis.

Parra ER, Lin F, Martins V, Rangel MP, Capelozzi VL.

J Bras Pneumol. 2013 Nov-Dec;39(6):692-700. doi: 10.1590/S1806-37132013000600008. English, Portuguese.

8.

Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia.

Harada T, Watanabe K, Nabeshima K, Hamasaki M, Iwasaki H.

Respirology. 2013 Feb;18(2):278-83. doi: 10.1111/j.1440-1843.2012.02272.x.

PMID:
23016880
9.

Radiological versus histopathological diagnosis of usual interstitial pneumonia in the clinical practice: does it have any survival difference?

Quadrelli S, Molinari L, Ciallella L, Spina JC, Sobrino E, Chertcoff J.

Respiration. 2010;79(1):32-7. doi: 10.1159/000225987. Epub 2009 Jun 19.

PMID:
19546518
10.

[Acute exacerbation of usual interstitial pneumonia and nonspecific interstitial pneumonia: analysis of 6 cases].

Tian XL, Xu WB, Shi JH, Feng RE, Xu ZJ, Liu HR, Wang MZ, Xu F, Huang H, Zhu YJ.

Zhonghua Jie He He Hu Xi Za Zhi. 2008 Apr;31(4):255-9. Chinese.

PMID:
18846960
11.

Frequency and implication of autoimmune serologies in idiopathic pulmonary fibrosis.

Moua T, Maldonado F, Decker PA, Daniels CE, Ryu JH.

Mayo Clin Proc. 2014 Mar;89(3):319-26. doi: 10.1016/j.mayocp.2013.11.018.

PMID:
24582190
12.

[Idiopathic pulmonary fibrosis; description of a Dutch cohort].

Barlo NP, van Moorsel CH, van den Bosch JM, van de Graaf EA, Kwakkel-van Erp JM, Grutters JC.

Ned Tijdschr Geneeskd. 2009;153:B425. Dutch.

PMID:
19785823
13.

Clinical findings and outcomes in patients with possible usual interstitial pneumonia.

Lee JW, Shehu E, Gjonbrataj J, Bahn YE, Rho BH, Lee MY, Choi WI.

Respir Med. 2015 Apr;109(4):510-6. doi: 10.1016/j.rmed.2015.02.008. Epub 2015 Feb 14.

14.

Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients.

Leslie KO, Cool CD, Sporn TA, Curran-Everett D, Steele MP, Brown KK, Wahidi MM, Schwartz DA.

Arch Pathol Lab Med. 2012 Nov;136(11):1366-76. doi: 10.5858/arpa.2011-0627-OAI.

PMID:
23106582
15.

Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.

Garin MC, Highland KB, Silver RM, Strange C.

J Rheumatol. 2009 Feb;36(2):330-6. doi: 10.3899/jrheum.080447. Epub 2009 Jan 22.

PMID:
19208563
16.

[The influence of pathological diagnosis on outcome in patients with idiopathic pulmonary fibrosis].

Tsuchiya T, Fujii M, Tsukamoto K, Sato M, Yagi T, Suda T, Chida K.

Nihon Kokyuki Gakkai Zasshi. 2010 Jul;48(7):469-74. Japanese.

PMID:
20684207
17.

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.

Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, Hansell DM, du Bois RM, Wells AU.

Eur Respir J. 2010 Apr;35(4):830-6. doi: 10.1183/09031936.00155108. Epub 2009 Oct 19.

18.

Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis.

Oda K, Ishimoto H, Yamada S, Kushima H, Ishii H, Imanaga T, Harada T, Ishimatsu Y, Matsumoto N, Naito K, Yatera K, Nakazato M, Kadota J, Watanabe K, Kohno S, Mukae H.

Respir Res. 2014 Sep 1;15:109. doi: 10.1186/s12931-014-0109-y.

19.

The 15-step oximetry test: a reliable tool to identify candidates for lung transplantation among patients with idiopathic pulmonary fibrosis.

Shitrit D, Rusanov V, Peled N, Amital A, Fuks L, Kramer MR.

J Heart Lung Transplant. 2009 Apr;28(4):328-33. doi: 10.1016/j.healun.2008.12.019.

PMID:
19332258
20.

Idiopathic pulmonary fibrosis--clinical presentation, outcome and baseline prognostic factors in a Portuguese cohort.

Soares Pires F, Caetano Mota P, Melo N, Costa D, Jesus JM, Cunha R, Guimarães S, Souto-Moura C, Morais A.

Rev Port Pneumol. 2013 Jan-Feb;19(1):19-27. doi: 10.1016/j.rppneu.2012.05.002. Epub 2012 Jul 20. English, Portuguese.

Supplemental Content

Support Center